OliPass Corp banner
O

OliPass Corp
KOSDAQ:244460

Watchlist Manager
OliPass Corp
KOSDAQ:244460
Watchlist
Price: 1 651 KRW -13.92% Market Closed
Market Cap: ₩13.4B

OliPass Corp
Investor Relations

OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Shin Chung Ph.D.
Founder & CEO
No Bio Available
Jae-Hyeon Kim
Finance Director
No Bio Available
Dr. Heungsik Yoon Ph.D.
Senior Vice President
No Bio Available

Contacts

Address
GYEONGGI-DO
Yongin
20F, 1 Dong, Ace Dongbaek Tower, 16-4, Dongbaekjungang-ro 16beon-gil, Giheung-gu
Contacts
+82264882200
www.olipass.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett